Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
The renin-angiotensin-aldosterone system (RAAS) is a major regulator of blood pressure. The octapeptide angiotensin II (AII) is proteolytically processed from the decapeptide AI by angiotensin-converting enzyme (ACE), and then acts via angiotensin type 1 and type 2 receptors (AT1R and AT2R). Inhibitors of ACE and antagonists of the AT1R are used in the treatment of hypertension, myocardial infarction, and stroke. We now show that the RAAS also plays a major role in autoimmunity, exemplified by multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Using proteomics, we observed that RAAS is up-regulated in brain lesions of MS. AT1R was induced in myelin-specific CD4+ T cells and monocytes during autoimmune neuroinflammation. Blocking AII production with ACE inhibitors or inhibiting AII signaling with AT1R blockers suppressed autoreactive TH1 and TH17 cells and promoted antigen-specific CD4+FoxP3+ regulatory T cells (Treg cells) with inhibition of the canonical NF-kappaB1 transcription factor complex and activation of the alternative NF-kappaB2 pathway. Treatment with ACE inhibitors induces abundant CD4+FoxP3+ T cells with sufficient potency to reverse paralytic EAE. Modulation of the RAAS with inexpensive, safe pharmaceuticals used by millions worldwide is an attractive therapeutic strategy for application to human autoimmune diseases.
Platten
Michael
M
Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University, Stanford, CA 94305, USA. michael.platten@med.-uni-heidelberg.de
Youssef
Sawsan
S
Hur
Eun Mi
EM
Ho
Peggy P
PP
Han
May H
MH
Lanz
Tobias V
TV
Phillips
Lori K
LK
Goldstein
Matthew J
MJ
Bhat
Roopa
R
Raine
Cedric S
CS
Sobel
Raymond A
RA
Steinman
Lawrence
L
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D005260:Female; D051858:Forkhead Transcription Factors / Q000276:immunology; D006801:Humans; D020381:Interleukin-17 / Q000276:immunology; D051379:Mice; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000378:metabolism; D044139:Receptor, Angiotensin, Type 2 / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000201:enzymology / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000201:enzymology / Q000276:immunology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; D020381:Interleukin-17; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D007703:Peptidyl-Dipeptidase A
Immunopharmacol Immunotoxicol. 1995 Aug;17(3):471-91
8576541
Rheumatology (Oxford). 2005 Jan;44(1):24-31
15353612
Nat Rev Immunol. 2006 Jul;6(7):508-19
16778830
Arch Neurol. 1997 Aug;54(8):1012-5
9267976
Nat Med. 2007 Feb;13(2):139-45
17290272
Arthritis Rheum. 2005 Jun;52(6):1920-8
15934096
J Clin Invest. 2007 Nov;117(11):3306-15
17965773
J Immunol. 2002 Oct 15;169(8):4388-98
12370372
Nature. 2008 Feb 28;451(7182):1076-81
18278032
Nature. 2003 Jan 30;421(6922):551-4
12540854
Acta Neurol Scand. 2006 Dec;114(6):374-7
17083336
Nat Immunol. 2005 Jul;6(7):715-21
15924143
Hypertension. 1991 Apr;17(4):589-92
2013486
Neuroimmunomodulation. 2004;11(3):173-80
15067208
Immunity. 2002 Nov;17(5):583-91
12433365
Nat Med. 2006 Feb;12(2):178-80
16462800
J Clin Invest. 2002 Sep;110(6):843-50
12235116
Immunity. 2008 Apr;28(4):477-87
18400190
Nat Med. 1999 Oct;5(10):1110-3
10502801
Annu Rev Immunol. 2004;22:361-403
15032582
Immunol Rev. 2006 Aug;212:203-16
16903916
J Clin Invest. 2001 Sep;108(5):739-47
11544280
Nature. 2005 Jun 2;435(7042):612-9
15931214
Cell. 1995 Jan 27;80(2):331-40
7834753
J Immunol. 2005 Oct 15;175(8):5077-86
16210611
J Exp Med. 2004 Jul 5;200(1):79-87
15238607
Nat Clin Pract Cardiovasc Med. 2004 Nov;1(1):42-7
16265259
J Exp Med. 2007 Oct 1;204(10):2449-60
17875676
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15577-82
9861011
J Immunol. 2007 Apr 15;178(8):4901-7
17404271
Hypertension. 2004 Sep;44(3):277-82
15302839